AU2001290761A1 - Methods of diagnosing breast cancer and screening for modulators - Google Patents
Methods of diagnosing breast cancer and screening for modulatorsInfo
- Publication number
- AU2001290761A1 AU2001290761A1 AU2001290761A AU9076101A AU2001290761A1 AU 2001290761 A1 AU2001290761 A1 AU 2001290761A1 AU 2001290761 A AU2001290761 A AU 2001290761A AU 9076101 A AU9076101 A AU 9076101A AU 2001290761 A1 AU2001290761 A1 AU 2001290761A1
- Authority
- AU
- Australia
- Prior art keywords
- modulators
- screening
- methods
- breast cancer
- diagnosing breast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
- A61K47/6855—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65834100A | 2000-09-08 | 2000-09-08 | |
US09/657,960 | 2000-09-08 | ||
US09/657,960 US6649342B1 (en) | 1999-03-15 | 2000-09-08 | Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators |
US09/658,341 | 2000-09-08 | ||
PCT/US2001/028375 WO2002021134A2 (en) | 2000-09-08 | 2001-09-10 | Methods of diagnosing breast cancer and screening for modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001290761A1 true AU2001290761A1 (en) | 2002-03-22 |
Family
ID=27097529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001290761A Abandoned AU2001290761A1 (en) | 2000-09-08 | 2001-09-10 | Methods of diagnosing breast cancer and screening for modulators |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001290761A1 (en) |
WO (1) | WO2002021134A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100354303C (en) * | 2005-01-18 | 2007-12-12 | 北京大学 | GIBC gene and its coded protein and uses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4614472B2 (en) * | 1996-10-31 | 2011-01-19 | アボット・ラボラトリーズ | Reagents and methods useful for detecting breast disease |
CA2283636A1 (en) * | 1997-03-20 | 1998-09-24 | Variagenics, Inc. | Target genes for allele-specific drugs |
-
2001
- 2001-09-10 AU AU2001290761A patent/AU2001290761A1/en not_active Abandoned
- 2001-09-10 WO PCT/US2001/028375 patent/WO2002021134A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002021134A2 (en) | 2002-03-14 |
WO2002021134A3 (en) | 2003-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002215345A1 (en) | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer | |
AU2002245317A1 (en) | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer | |
AU2002330039A1 (en) | Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer | |
AU2002249871A1 (en) | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | |
AU2002316576A1 (en) | Diagnostic and screening methods for bladder cancer | |
AU2002347428A1 (en) | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer | |
AU2001231199A1 (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
WO2002068677A8 (en) | Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer | |
AU3105700A (en) | Methods for detection of antiestrogen-resistant breast cancer | |
AU2002243549A1 (en) | Diagnostic and monitoring methods for cancer | |
AU3755300A (en) | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | |
AU1465801A (en) | Methods for cancer prognosis and diagnosis | |
AU2002231979A1 (en) | Modulators of p53-p300 interactions and screening methods therefor | |
AU2001290902A1 (en) | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators | |
AU3391200A (en) | Compositions and methods for breast cancer therapy and diagnosis | |
AU2002348297A1 (en) | Proteonomic methods for diagnosis and monitoring of breast cancer | |
AU5005697A (en) | Methods of preventing breast cancer | |
AU2002239268A1 (en) | Method and system for ultrasound breast cancer screening | |
AU8259798A (en) | Method for detection of breast cancer | |
AU2001243349A1 (en) | Methods for the diagnosis and treatment of breast cancer | |
AU2948199A (en) | Breast cancer antigen | |
GB0011439D0 (en) | Cancer diagnosis and assays for screening | |
AU4150999A (en) | Method and kit for early diagnosis of cancer | |
AU2001283463A1 (en) | Methods of diagnosis of cancer and screening for cancer modulators | |
EP1380840A4 (en) | Method of diagnosing breast cancer |